← Open Payments lookup

MELODY EVANS: Open Payments

NPI 1174050447 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,623 in 71 payments from 18 companies in 2025. Trend: 2023 $597 · 2024 $2,390 · 2025 $1,623

Food & beverage: $1,623
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.10$256
GlaxoSmithKline, LLC.12$236
Verona Pharma, Inc.13$220
AstraZeneca Pharmaceuticals LP7$148
Takeda Pharmaceuticals U.S.A., Inc.4$146
GENZYME CORPORATION5$143
Actelion Pharmaceuticals US, Inc.4$90
Mallinckrodt Hospital Products Inc.3$79
United Therapeutics Corporation3$68
Amgen Inc.2$48

Products named: DUPIXENT, Ohtuvayre, NUCALA, TEZSPIRE, GLASSIA, Tyvaso, OPSUMIT, ACTHAR.

Industry payments across MD — which companies pay providers there.